The Efficacy of Enternal Nutrition in Active Ulcerative Colitis Patients with Hypoalbuminemia ,during Infliximab Therapy

The Efficacy of Enternal Nutrition in Active Ulcerative Colitis Patients with Hypoalbuminemia ,during Infliximab Therapy - The Efficacy of Enternal Nutrition in Active Ulcerative Colitis Patients with Hypoalbuminemia ,during Infliximab Therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018745

Enrollment

Registered

2015-09-01

Start date

2015-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis

Interventions

Administration of Infliximab and enteral nutrition Administration of Infliximab

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: UC patients meeting criteria established by the Reseach Committee of Specified Diseases/of Health,Labour and Welfare,and items below. 1.Lichtiger CAI >4 2.UCEIS>3 3.Total colitis,left-sided colitis

Exclusion criteria

Exclusion criteria: 1.Proctitis 2.Fluminating type 3.Severe ulcer,massive bleeding,perforation,toxic megacolon 4.Severe conplication 5.Allergic disease 6.Patients who reciept infusion of anti-TNF alpha antibody within 6 months 7.Pregnancy

Design outcomes

Primary

Measure	Time frame
Diffarence of remission rate or improvement rate between two group	—

Secondary

Measure	Time frame
Difference of IFX trough between two group. Relationship of IFX trough and serum albmin,and improvement rate.	—

Countries

Japan

Contacts

Public ContactTsunaki Sawada

Nagoya University Graduate School of Medicine Department of Gastroenterology and Hepatology

t.sawada@med.nagoya-u.ac.jp+81-52-741-2172

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026